AI Day1 LLC

Average Profitability
13.88%
Insider Buys Quantity
8
Insider Buys Sum
$54.53M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of AI Day1 LLC

According to the SEC Form 4 filings, AI Day1 LLC, being in a position of

  1. 10 percent owner at Day One Biopharmaceuticals, Inc.,
    оver the last 12 months, has bought 1475454 shares for $14.98M, and sold 0 shares,
    over all time since 2021-06-01, has bought 4101546 shares for $54.53M, and sold 0 shares.

The largest purchase of all time was on 2021-06-01 and amounted to 1750000 shares of Day One Biopharmaceuticals, Inc. for $28M.

Biography of AI Day1 LLC

No biography is available at this moment.

2023-10-20PurchaseDay One Biopharmaceuticals, Inc.
DAWN
10 percent owner
111,387
0.132%
$9.97$1.11M+46.28%
2023-10-19PurchaseDay One Biopharmaceuticals, Inc.
DAWN
10 percent owner
384,400
0.4462%
$10.06$3.87M+42.03%
2023-10-18PurchaseDay One Biopharmaceuticals, Inc.
DAWN
10 percent owner
979,667
1.1163%
$10.21$10M+37.2%
2023-06-09PurchaseDay One Biopharmaceuticals, Inc.
DAWN
10 percent owner
769,230
1.0704%
$13.00$10M+6.16%
2022-01-20PurchaseDay One Biopharmaceuticals, Inc.
DAWN
10 percent owner
4,615
0.0079%
$14.73$67,976+24.9%
2022-01-19PurchaseDay One Biopharmaceuticals, Inc.
DAWN
10 percent owner
58,818
0.1007%
$14.70$864,566+24.41%
2022-01-18PurchaseDay One Biopharmaceuticals, Inc.
DAWN
10 percent owner
43,429
0.0744%
$14.26$619,367+28.26%
2021-06-01PurchaseDay One Biopharmaceuticals, Inc.
DAWN
10 percent owner
1.75M
5.8007%
$16.00$28M-14.32%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.